Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Jul;50(1):113–117. doi: 10.1038/bjc.1984.146

5-fluorouracil metabolism monitored in vivo by 19F NMR.

A N Stevens, P G Morris, R A Iles, P W Sheldon, J R Griffiths
PMCID: PMC1976923  PMID: 6743508

Full text

PDF
115

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alger J. R., Sillerud L. O., Behar K. L., Gillies R. J., Shulman R. G., Gordon R. E., Shae D., Hanley P. E. In vivo carbon-13 nuclear magnetic resonance studies of mammals. Science. 1981 Nov 6;214(4521):660–662. doi: 10.1126/science.7292005. [DOI] [PubMed] [Google Scholar]
  2. Ardalan B., Glazer R. An update on the biochemistry of 5-fluorouracil. Cancer Treat Rev. 1981 Sep;8(3):157–167. doi: 10.1016/s0305-7372(81)80014-x. [DOI] [PubMed] [Google Scholar]
  3. Au J. L., Rustum Y. M., Ledesma E. J., Mittelman A., Creaven P. J. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas. Cancer Res. 1982 Jul;42(7):2930–2937. [PubMed] [Google Scholar]
  4. Bedikian A. Y., Stroehlein J. R., Karlin D. A., Bennetts R. W., Bodey G. P., Valdivieso M. Chemotherapy for colorectal cancer with a combination of PALA and 5-FU. Cancer Treat Rep. 1981 Sep-Oct;65(9-10):747–753. [PubMed] [Google Scholar]
  5. Carrico C. K., Glazer R. I. Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver. Cancer Res. 1979 Sep;39(9):3694–3701. [PubMed] [Google Scholar]
  6. Goulian M., Bleile B., Tseng B. Y. Methotrexate-induced misincorporation of uracil into DNA. Proc Natl Acad Sci U S A. 1980 Apr;77(4):1956–1960. doi: 10.1073/pnas.77.4.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Griffiths J. R., Cady E., Edwards R. H., McCready V. R., Wilkie D. R., Wiltshaw E. 31P-NMR studies of a human tumour in situ. Lancet. 1983 Jun 25;1(8339):1435–1436. doi: 10.1016/s0140-6736(83)92375-9. [DOI] [PubMed] [Google Scholar]
  8. Kirkwood J. M., Ensminger W., Rosowsky A., Papathanasopoulos N., Frei E., 3rd Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial. Cancer Res. 1980 Jan;40(1):107–113. [PubMed] [Google Scholar]
  9. Pogolotti A. L., Jr, Nolan P. A., Santi D. V. Methods for the complete analysis of 5-fluorouracil metabolites in cell extracts. Anal Biochem. 1981 Oct;117(1):178–186. doi: 10.1016/0003-2697(81)90708-9. [DOI] [PubMed] [Google Scholar]
  10. Sakurai Y. Studies of analogs of fluorinated pyrimidine in Japan. Recent Results Cancer Res. 1981;76:91–99. doi: 10.1007/978-3-642-81565-2_8. [DOI] [PubMed] [Google Scholar]
  11. Sommadossi J. P., Gewirtz D. A., Diasio R. B., Aubert C., Cano J. P., Goldman I. D. Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography. J Biol Chem. 1982 Jul 25;257(14):8171–8176. [PubMed] [Google Scholar]
  12. Spiegelman S., Nayak R., Sawyer R., Stolfi R., Martin D. Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA. Cancer. 1980 Mar 15;45(5 Suppl):1129–1134. doi: 10.1002/1097-0142(19800315)45:5+<1129::aid-cncr2820451317>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES